Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Acquisition

11 Apr 2017 15:30

RNS Number : 2115C
Exova Group PLC
11 April 2017
Β 

Β 

STOCK EXCHANGE RELEASE

Β 

11 April 2017

Exova Group plc

Β 

Exova acquires SL Pharma Labs Incorporated

Β 

Exova Group plc ("Exova") EXO.L, the global testing, calibration and advisory services provider, has acquired SL Pharma Labs Incorporated (SL Pharma), a Delaware, US, based business that provides laboratory and clinical manufacture testing services to pharmaceutical, biotechnology and medical device companies.

Founded in 1997, SL Pharma has built a strong reputation in the provision of high value and high quality pharmaceutical product development and testing services focused primarily on the development and clinical manufacture of parenteral, ophthalmic, intranasal and topical drug products. The business has a team of 14 specialists and achieved revenues of around $2.5m in 2016.

Ian El-Mokadem, Chief Executive Officer at Exova, said: "This acquisition complements our existing operations by enhancing Exova's technical expertise in pharmaceutical services and offers a great foundation for further growth in North America. SL Pharma's addition to our portfolio clearly demonstrates our commitment to providing more technically demanding services and developing our capabilities in new markets."

Β 

ENDS

Β 

Β 

Enquiries:

Β 

Andy Jones

Powerscourt

T: +44 (0) 20 7549 0747

E: andy.jones@exova.com

Β 

Andrew Pickup

Corporate Affairs Director, Exova Group plc

T: +44 (0) 7920 243 393

E: andrew.pickup@exova.com

Exova

Β 

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 135 laboratories and offices in 33 countries and employs around 4,200 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors ranging from Aerospace to Fire & Building Products; Oil & Gas and Industrials; Infrastructure & Environment; Transportation; and Health Sciences.

Exova Group plc is registered in England (registration number 08907086). Its legal entity identifier ('LEI') number is 213800BFE317FGSYMZ19.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQBBGDSSGBBGRB
Date   Source Headline
12th May 201711:19 amRNSForm 8.3 - Exova Group PLC
12th May 201711:08 amRNSForm 8.5 (EPT/RI)
12th May 201710:25 amRNSForm 8.5 (EPT/RI)
12th May 20177:00 amRNSPublication and posting of Scheme Document
11th May 201711:44 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
11th May 201710:40 amRNSForm 8.5 (EPT/RI)
11th May 201710:14 amRNSForm 8.3 - Exova Group PLC
10th May 201712:45 pmRNSForm 8.3 - Exova Group PLC
10th May 201711:20 amRNSForm 8.5 (EPT/RI)
10th May 201711:16 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
10th May 201711:05 amRNSForm 8.5 (EPT/RI)
9th May 201712:18 pmRNSForm 8.3 - Exova Group Plc
9th May 201711:53 amRNSForm 8.5 (EPT/NON-RI) - Exova Group Plc
9th May 201711:36 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
9th May 201711:33 amRNSForm 8.5 (EPT/RI)
9th May 201710:59 amRNSForm 8.5 (EPT/RI)
9th May 20179:59 amRNSForm 8.3 - Exova Group Plc
8th May 20173:20 pmRNSForm 8.3 - Exova Group Plc
8th May 20172:37 pmRNSForm 8.3 - Exova PLC
8th May 201711:37 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
8th May 201711:35 amRNSForm 8.5 (EPT/RI)
8th May 201711:23 amRNSForm 8.3 - Exova Group Plc
8th May 201710:45 amRNSForm 8.5 (EPT/RI)
5th May 20172:27 pmRNSForm 8.3 - Exova Group PLC
5th May 201711:25 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
5th May 201711:21 amRNSForm 8.5 (EPT/RI)
5th May 201710:58 amRNSForm 8.3 - Exova Group Plc
4th May 201711:44 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
4th May 201711:16 amRNSForm 8.3 - Exova Group Plc
3rd May 20172:57 pmRNSForm 8.3 - Exova Group Plc
3rd May 201711:40 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
3rd May 201710:57 amRNSForm 8.5 (EPT/RI)
2nd May 20173:30 pmRNSForm 8.3 - EXO LN
2nd May 20173:10 pmRNSForm 8.3 - Exova Group Plc
2nd May 201711:38 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
2nd May 201710:28 amRNSForm 8.5 (EPT/RI)
2nd May 20177:00 amRNSForm 8.3 - Exova Group Plc
28th Apr 20173:29 pmRNSForm 8.3 - Exova Group Plc
28th Apr 201711:41 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
28th Apr 201711:25 amRNSForm 8.5 (EPT/RI)
28th Apr 201711:15 amRNSForm 8.3 - Exova Group Plc
28th Apr 201711:02 amRNSForm 8.5 (EPT/RI)
27th Apr 201712:21 pmRNSForm 8.5 (EPT/RI)
27th Apr 201711:53 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
27th Apr 201711:04 amRNSForm 8.5 (EPT/RI)
26th Apr 20172:14 pmBUSForm 8.3 - Exova Group Plc
26th Apr 201711:17 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
25th Apr 20172:44 pmBUSForm 8.3 - Exova Group Plc
25th Apr 201711:31 amRNSForm 8.5 (EPT/RI) Exova Group Plc
24th Apr 20175:29 pmRNSForm 8.5 (EPT/RI) - Exova Group Plc - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.